Skip to content

Preventive effect of transcutaneous acupoint electrical stimulation with different time duration on postoperative delirium in elderly patients with gastrointestinal tumors

Preventive effect of transcutaneous acupoint electrical stimulation with different time duration on postoperative delirium in elderly patients with gastrointestinal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005342
Enrollment
Unknown
Registered
2021-11-27
Start date
2021-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Treatment from induction to the end of surgery group:TEAS will be applied on Neiguan and Hegu acupoints from anesthesia induction with dense waves, the maximum intensity that patients can tolerate unt
Control group:The electrode tablets will be placed on Neiguan and Hegu acupoints 30 minutes before anesthesia induction to the end of surgery without electrical stimulation.
Pretreatment group:TEAS will be applied on Neiguan and Hegu acupoints 30 minutes before anesthesia induction with dense waves, the maximum intensity that patients can tolerate until the anesthesia ind
Treatment before induction to the end of surgery group:TEAS will be applied on Neiguan and Hegu acupoints 30 minutes before anesthesia induction with dense waves, the maximum intensity that patients c

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who plan to undergo transabdominal gastrointestinal tumor surgery under general anesthesia. Age = 65 years, ASA I ~ II.

Exclusion criteria

Exclusion criteria: (1)Dementia, delirium or a history of neurological and mental illness caused by various causes; (2)Using sedative or antidepressants; (3)A history of alcohol or drug dependence; (4)A history of endocrine or metabolic disorders or recent use of gluco corticosteroids or other hormones; (5)Planning to enter the ICU before surgery; (6)Suffering from infection or chronic inflammation and being used with anti-inflammatory drugs; (7)Traumas, breaks, infections, etc. in the area of electrical stimulation; (8)Suffering from severe arrhythmia; (9)Unwilling or unable to cooperate (language impairment, severe hearing, visual impairment) to complete the experiment.

Design outcomes

Primary

MeasureTime frame
CAM-ICU scale score;

Secondary

MeasureTime frame
Serum cholinesterase concentration;Serum C-reactive protein concentration;Serum total bilirubin concentration;

Countries

China

Contacts

Public ContactBo Fang
bfang@cmu.edu.cn13591652713

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026